Disease | transitional cell carcinoma |
Comorbidity | C0035412|rhabdomyosarcoma |
Sentences | 1 |
PubMedID- 21762516 | In practice, urothelial carcinoma with extensive rhabdomyosarcomatous differentiation can only be differentiated from de novo rhabdomyosarcoma based on finding of any carcinomatous (neoplastic epithelial) element and/or unequivocal cytokeratin immunoreactivity in tumor cells. |
Page: 1